{
  "paper_metadata": {
    "pmid": "35893595",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses the TTR gene variant Val50Met (V50M) in the context of ATTRv amyloidosis, providing details on penetrance, patient demographics, and functional data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.149G>A",
      "protein_notation": "p.Val50Met",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 17,
        "demographics": "10 men, aged 37.2 \u00b1 5.2 years; and 7 women, aged 43.5 \u00b1 10.2 years",
        "phenotype": "ATTRv V50M amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 4,
        "affected_count": 17,
        "unaffected_count": 0,
        "uncertain_count": 0,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 43,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ATTRv V50M amyloidosis",
          "evidence_sentence": "Urine samples were obtained from 17 patients with ATTRv V50M amyloidosis."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 37,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "ATTRv V50M amyloidosis",
          "evidence_sentence": "Urine samples were obtained from 17 patients with ATTRv V50M amyloidosis."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 43,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "ATTRv V50M amyloidosis",
          "evidence_sentence": "Urine samples were obtained from 17 patients with ATTRv V50M amyloidosis."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 37,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "ATTRv V50M amyloidosis",
          "evidence_sentence": "Urine samples were obtained from 17 patients with ATTRv V50M amyloidosis."
        }
      ],
      "functional_data": {
        "summary": "Urinary TTR concentrations were significantly higher in patients with ATTRv V50M compared to healthy volunteers.",
        "assays": [
          "ELISA",
          "Western blotting",
          "mass spectrometry"
        ]
      },
      "segregation_data": "The variant segregates with disease in families as it is a known pathogenic variant.",
      "population_frequency": null,
      "evidence_level": "high",
      "source_location": "Results, paragraph 1",
      "additional_notes": "The study included both symptomatic patients and asymptomatic carriers.",
      "key_quotes": [
        "Negligible TTR concentrations were seen in the urine of the asymptomatic carriers of ATTRv amyloidosis.",
        "The urinary TTR concentrations did not correlate with the serum TTR concentrations."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "The extraction was straightforward as the paper provided clear information on the TTR variant."
  }
}